Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice.

@article{Consroe1982EffectsOC,
  title={Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice.},
  author={P. Consroe and M. A. Benedito and J. Leite and E. Carlini and R. Mechoulam},
  journal={European journal of pharmacology},
  year={1982},
  volume={83 3-4},
  pages={
          293-8
        }
}
In mice, running, clonic and tonic convulsions and lethality were assessed following transcorneal (electroshock) current or convulsant drugs, each administered alone and after cannabidiol (CBD) pretreatment. CBD prevented tonic convulsions caused by a convulsant current (CC) 99.99, and by the convulsant dose (CD) 99.99 values of gamma-aminobutyric acid (GABA) inhibitors, 3-mercaptoproprionic acid (3MPA), picrotoxin (PIC), isonicotinic acid hydrazine (INH), pentylenetetrazol (PTZ) and… Expand
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels
TLDR
The robust anticonvulsant effects of CBD may result from multiple pharmacological mechanisms, including facilitation of endocannabinoid signaling and TRPV1 mechanisms, with potential implications for the development of new treatments for certain epileptic syndromes. Expand
Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice
TLDR
The results demonstrate that endocannabinoid system participates in the modulation of seizure and combination of small doses of exogenous CB1 receptor agonists with diazepam may have effective consequences in seizure control and suggests that the effects of cannabinoids on epilepsy depend on the relative cannabinoid responsiveness of GABAergic and glutamatergic neurotransmission. Expand
The role of α₂-adrenoceptors in the anti-convulsant effects of cannabinoids on pentylenetetrazole-induced seizure threshold in mice.
TLDR
It is demonstrated that α₂-adrenoceptors could be involved in the anticonvulsant properties of the specific cannabinoid CB⁁ agonist ACEA, suggesting that CB₁ cannabinoid and α⁂� receptors have functional interactions in modulation of clonic seizure threshold. Expand
The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice
TLDR
Results suggested a BK channel-mediated antiseizure action of cannabidiol in PTZ model of seizure, however, such an interaction might not exist in MES-induced convulsion. Expand
Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB1 agonist ACEA in the pentylenetetrazole-induced seizure in mice
TLDR
It is demonstrated that central NO system could be involved in the anticonvulsant properties of the specific cannabinoid CB(1) agonist ACEA, emphasizing on the interaction between two systems in the seizure modulation. Expand
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
TLDR
The effects of pure CBD are reported in two other established rodent seizure models, the acute pilocarpine model of temporal lobe seizure and the penicillin model of partial seizure to extend the anti-convulsant profile of CBD. Expand
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression
TLDR
These results provide the first molecular confirmation of behaviourally observed effects of the non-psychoactive, anticonvulsant cannabinoid, CBDV, upon chemically-induced seizures and serve to underscore its suitability for clinical development. Expand
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.
TLDR
A role for the cannabinoid CB1 receptor in modulating seizure activity in a whole animal model is established and it is established that the anticonvulsant effects of delta9-tetrahydrocannabinol and WIN 55,212-2 are cannabinoid CB 1 receptor-mediated while the anticoagulant activity of cannabidiol is not. Expand
An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol
TLDR
There is little evidence from the data that any of the THC effects studied were GABA mediated, and in vitro experiments with guinea pig ileum showed that the ability of THC to inhibit electrically evoked contractions was unaffected by delta-amino-n-valeric acid, and that preparations rendered tolerant to GABA responded normally to THC. Expand
Cannabidiol as a Treatment for Seizures, Convulsions and Epilepsy
TLDR
There remains a clear need for further studies of the structure-activity relationships and mechanisms of action of CBD-based formulations to ensure that the therapeutic indices of dosage formulations are clearly understood and optimized for patient populations. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
The Cannabinoids as Potential Antiepileptics
TLDR
The anticonvulsant nature of cannabidiol suggests that it has a therapeutic potential in at least three of the four major types of epilepsy: grand mal, cortical focal, and complex partial seizures. Expand
Anticonvulsant activity of four oxygenated cannabidiol derivatives.
TLDR
CBD, II, III and IV were also active in protecting mice against electroconvulsive shock at doses of 100-200 mg/kg, although at the larger dose CBD and compound II were the most efficient. Expand
Electrophysiologic Properties of the Cannabinoids
TLDR
The results clearly demonstrate the complexity of the CNS properties of THC and the selectivity of the depressant properties of cannabidiol and illustrate the wide range of neuropharmacologic responses that potentially any cannabinoid can effect. Expand
Effect of cannabinoids on neurotransmitter uptake, atpase activity and morphology of mouse brain synaptosomes
Δ1-Tetrahydrocannabinol (Δ1-THC) and cannabidiol (CBD), a psychoactive and a nonpsychoactive constituent of marijuana respectively, inhibit the uptake of 3H-labelled norepinephrine (NE), dopamineExpand
Gabaergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by Δ9-tetrahydrocannabinol
TLDR
It is suggested that Δ9-THC inhibits TRACh in the cholinergic septal-hippocampal pathway by increasing the release of GABA from sePTal GABAergic interneurons. Expand
Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
Injection of delta 1-tetrahydrocannabinol (THC) into mice increased the uptake into brain synaptosomes of radioactive DA, NE, 5-HT and GABA, with the effect on GABA being the greatest; uptake ofExpand
Antiepileptic Potential of Cannabidiol Analogs
TLDR
Findings of separation of anticonvulsant from neurotoxic and psychoactive activities, notably with CBD diacetate, suggest that additional structural modifications of CBD may yield novel antiepileptic drugs. Expand
Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes.
TLDR
Hydroxylation of C-7 in delta6-THC does not alter inhibitory potency, but its oxidation to an acid and aromatization of ring A greatly reduce affinity, which is critical for inhibition of NE, 5-HT and GABA uptake. Expand
Chronic administration of cannabidiol to healthy volunteers and epileptic patients.
TLDR
Four of the 8 CBD subjects remained almost free of convulsive crises throughout the experiment and 3 other patients demonstrated partial improvement in their clinical condition, while CBD was ineffective in 1 patient. Expand
Laboratory Evaluation of Antiepileptic Drugs
The historical development of the laboratory evaluation of anticonvulsant drugs was briefly reviewed. Attention was directed to the fact that such evaluation can be approached from several biologicalExpand
...
1
2
3
...